Senti Biosciences Holdings's top three insider shareholders as of May 30, 2026 are Partners Spv 24 Celadon (TenPercentOwner, 9.78Mn shares), Omid Farokhzad (Director, 8.66Mn shares), Enterprise Associates 15, L.P. New (TenPercentOwner, 3.78Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Healthcare Llc Bayer | - | 2,809,848 | 0 | 12 Mar, 2025 |
| Omid Farokhzad | - | 0 | 8,662,903 | 10 Jun, 2022 |
| Enterprise Associates 15, L.P. New | - | 3,775,615 | 0 | 12 Mar, 2025 |
| Kanya Rajangam | Pres. Chief Med. Dev. Off. | 74,843 | 0 | 09 Mar, 2026 |
| Timothy K Lu | Ceo | 639,583 | 0 | 09 Mar, 2026 |
| Deborah Knobelman | Chief Financial Officer | 131,000 | 0 | 02 Feb, 2024 |
| Partners Spv 24 Celadon | - | 9,777,000 | 0 | 14 Mar, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 09 Mar, 2026 | Timothy K Lu | Common Stock | D | 80,666 | $0.00 | 639,583 | D | F |
| 09 Mar, 2026 | Kanya Rajangam | Common Stock | D | 10,757 | $0.00 | 74,843 | D | F |
| 02 Feb, 2026 | Timothy K Lu | Common Stock | D | 4,191 | $0.00 | 720,249 | D | F |
| 02 Feb, 2026 | Kanya Rajangam | Common Stock | D | 1,384 | $0.00 | 85,600 | D | F |
| 18 Jul, 2025 | Bryan Daniel Baum | Stock Option (Right to Buy) | A | 43,900 | $0.00 | 43,900 | D | A |
| 25 Jun, 2025 | Feng Hsiung | Stock Option (Right to Buy) | A | 21,950 | $0.00 | 21,950 | D | A |
| 25 Jun, 2025 | James J. Collins | Stock Option (Right to Buy) | A | 21,950 | $0.00 | 21,950 | D | A |
| 25 Jun, 2025 | Fran Schulz | Stock Option (Right to Buy) | A | 21,950 | $0.00 | 21,950 | D | A |
| 25 Jun, 2025 | Brenda Cooperstone | Stock Option (Right to Buy) | A | 21,950 | $0.00 | 21,950 | D | A |
| 25 Jun, 2025 | Edward T Mathers | Stock Option (Right to Buy) | A | 21,950 | $0.00 | 21,950 | D | A |
| 10 Mar, 2025 | Partners Spv 24 Celadon | Common Stock | A | 9,777,000 | - | 9,777,000 | D | C |
| 10 Mar, 2025 | Partners Spv 24 Celadon | Series A Convertible Preferred Stock | D | 9,777 | - | 0 | D | C |
| 10 Mar, 2025 | Enterprise Associates 15, L.P. New | Common Stock | A | 3,333,000 | - | 3,775,615 | D | C |
| 10 Mar, 2025 | Healthcare Llc Bayer | Common Stock | A | 2,222,000 | - | 2,809,848 | D | C |
| 10 Mar, 2025 | Healthcare Llc Bayer | Common Stock | A | 2,222,000 | - | 2,809,848 | D | C |
| 10 Mar, 2025 | Healthcare Llc Bayer | Common Stock | A | 2,222,000 | - | 2,809,848 | D | C |
| 10 Mar, 2025 | Enterprise Associates 15, L.P. New | Common Stock | A | 3,333,000 | - | 3,775,615 | D | C |
| 10 Mar, 2025 | Enterprise Associates 15, L.P. New | Common Stock | A | 3,333,000 | - | 3,775,615 | D | C |
| 10 Mar, 2025 | Enterprise Associates 15, L.P. New | Common Stock | A | 3,333,000 | - | 3,775,615 | D | C |
| 10 Mar, 2025 | Enterprise Associates 15, L.P. New | Common Stock | A | 3,333,000 | - | 3,775,615 | D | C |